To Evaluate the Rate of Digestive and Urinary Toxicity

Clinical trial pipeline · Data from ClinicalTrials.gov

See which To Evaluate the Rate of Digestive and Urinary Toxicity trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT03417336

Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in…

The standard treatment of high-risk prostatic adenocarcinoma is based on pelvic-prostatic external radiotherapy combined with concomitant and adjunctive hormone…

France90 participantsStarted 2018-01-24

Treatment: prostatic boost in brachytherapy with high dose rate (HDR)

To Evaluate the Rate of Digestive and Urinary Toxicity

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in…

All recent trials (1 shown)